TheraVasc Raises $500k
TheraVasc, a Cleveland-based commercializer of a treatment for peripheral artery disease, has raised $500,000 in VC funding from JumpStart Inc. and Portal Capital.
6 January 2010•3 mins read
TheraVasc, a Cleveland-based commercializer of a treatment for peripheral artery disease, has raised $500,000 in VC funding from JumpStart Inc. and Portal Capital.
